ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF
申请人:Enanta Pharmaceuticals, Inc.
公开号:US20180099957A1
公开(公告)日:2018-04-12
The present invention provides compounds of Formula I,
pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Isoxazole analogs as FXR agonists and methods of use thereof
申请人:Enanta Pharmaceuticals, Inc.
公开号:US10450306B2
公开(公告)日:2019-10-22
The present invention provides compounds of Formula I,
pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
本发明提供了式 I 的化合物、
包含这些化合物的药物组合物,以及使用这些化合物预防或治疗 FXR 介导或 TGR5 介导的疾病或病症的方法。
Regioselectivity in the Friedel-Crafts tert-Butylation of 1-Naphthol